Stephen Zachary

Stephen Zachary is an accomplished professional with a strong educational background in Neuroscience, holding a Doctor of Philosophy (PhD) from The Johns Hopkins University School of Medicine.

He pursued his undergraduate studies at Washington and Lee University and completed his high school education at Gonzaga College High School.

Currently, Stephen Zachary serves as the Principal at Sands Capital Ventures, showcasing his leadership skills and business acumen.

His previous roles include being a Board Member at DiCE Molecules and a Kauffman Fellow (Class 23) at Kauffman Fellows, indicating his involvement in strategic decision-making and investment activities.

Moreover, Stephen Zachary has held positions such as Board Member at Day Zero Diagnostics, Inc, Board Observer at nanoView Diagnostics Inc, Director of Research Analytics at Agilis Biotherapeutics Inc, and Board Observer at Agilis Biotherapeutics Inc, demonstrating his diverse experience in the biotechnology and pharmaceutical sectors.